| abstract |
1. The compound according to claim 1, characterized in that it has the formula: wherein R1 is selected from the group consisting of aryl (C4-12) and heteroaryl (C1-10), each substituted or unsubstituted; R2 is hydrogen; R4 and R5 are each independently selected from the group consisting of hydrogen and substituted or unsubstituted (C1-5) alkyl; R9 is hydrogen; and R11 is selected from the group consisting of hydrogen, (C1-10) alkyl, halo (C1-10) alkyl, C1-3 carbonylalkyl), thiocarbonylalkyl (C1-3), sulfonylalkyl (C1-3) alkyl, sulfinyl (C1-3) alkyl ), amino (C1-10) alkyl, iminoalkyl (C1-3), cycloalkyl (C3-12) alkyl (C1-5), heterocycloalkyl (C3-12) alkyl (C1-5), arylalkyl (C1-10), heteroarylalkyl (C1-5) bicycloaryl (C9-12) alkyl (C1-5), heterobicycloaryl (C8-12) alkyl (C1-5), cycloalkyl (C3-12), heterocycloalkyl (C3-12), bicycloalkyl (C9-12 ), heterobicycloalkyl (C3-12), aryl (C4-12), heteroaryl (C1-10), bicycloaryl (C9-12) and heterobicycloaryl (C4-C12), each substituted or unsubstituted; and pharmaceutically acceptable salts thereof. 2. The compound according to claim 1, characterized in that it has the formula: wherein L is a substituted or unsubstituted (C1-10) alkylene; and R12 is selected from the group consisting of hydroxyl, cycloalkyl (C3-12) and heterocycloalkyl (C3-12), each substituted or unsubstituted. |